Literature DB >> 2268214

Desmoplastic, neural transforming and neurotropic melanoma: a review of 45 cases.

B M Smithers1, G R McLeod, J H Little.   

Abstract

An analysis of the clinicopathological features of 45 cases of desmoplastic, neural transforming and neurotropic melanoma assessed by a single pathologist are reported. The age range of 27 males and 18 females was 17-88 years. Twenty primary lesions (44%) were on the head and neck and fourteen (31%) were on the trunk. Thirty lesions (67%) were amelanotic. The initial clinical diagnosis was incorrect for 16 patients. Mean thickness was 4.5 mm. Recurrence occurred in 17 patients (38%). Local recurrence has occurred in 12 patients. This was related to a primary where: pathological diagnosis was incorrect; excision was less than 1 cm; the site was on the head and neck; Clarke level was V; and Breslow thickness was greater than 4 mm. Four patients had cranial nerve neuropathies due to recurrent neurotropic melanoma. Four patients are alive with inoperable disease and five have died from disseminated melanoma. These tumours can be difficult to recognize clinically and pathologically, with poor results if not adequately treated primarily. Therefore, the need for surgeons to be aware of this tumour and its clinicopathological features is important. Close follow-up is essential.

Entities:  

Mesh:

Year:  1990        PMID: 2268214     DOI: 10.1111/j.1445-2197.1990.tb07515.x

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN: 0004-8682


  7 in total

1.  Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral center.

Authors:  Alexander H R Varey; Chris Goumas; Angela M Hong; Graham J Mann; Gerald B Fogarty; Jonathan R Stretch; Robyn P M Saw; Andrew J Spillane; Kerwin F Shannon; Kenneth J Lee; Michael J Quinn; John F Thompson; Richard A Scolyer
Journal:  Mod Pathol       Date:  2017-07-21       Impact factor: 7.842

2.  Roles of adjuvant and salvage radiotherapy for desmoplastic melanoma.

Authors:  Daniel E Oliver; Kirtesh R Patel; Jeffrey Switchenko; Douglas Parker; David H Lawson; Keith A Delman; Ragini R Kudchadkar; Mohammad K Khan
Journal:  Melanoma Res       Date:  2016-02       Impact factor: 3.599

3.  [Desmoplastic neurotropic melanoma. Diagnosis and therapeutic procedures for a rare clinical entity].

Authors:  J Hauser; H-H Homann; D Drücke; C Kuhnen; S A Esenwein; H-U Steinau
Journal:  Chirurg       Date:  2006-10       Impact factor: 0.955

4.  Desmoplastic melanoma: patterns of recurrence.

Authors:  B M Smithers; G R McLeod; J H Little
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

5.  Radiotherapy influences local control in patients with desmoplastic melanoma.

Authors:  Tobin Strom; Jimmy J Caudell; Dale Han; Jonathan S Zager; Daohai Yu; C Wayne Cruse; Suroosh S Marzban; Jane L Messina; Andy M Trotti; Vernon K Sondak; Nikhil G Rao
Journal:  Cancer       Date:  2013-10-18       Impact factor: 6.860

Review 6.  Malignant melanoma with neural differentiation: an exceptional case report and brief review of the pertinent literature.

Authors:  Albert Su; Sarah M Dry; Scott W Binder; Jonathan Said; Peter Shintaku; G Peter Sarantopoulos
Journal:  Am J Dermatopathol       Date:  2014-01       Impact factor: 1.533

7.  Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR).

Authors:  Richard A Scolyer; Meagan J Judge; Alan Evans; David P Frishberg; Victor G Prieto; John F Thompson; Martin J Trotter; Maureen Y Walsh; Noreen M G Walsh; David W Ellis
Journal:  Am J Surg Pathol       Date:  2013-12       Impact factor: 6.394

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.